These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34943575)

  • 21. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
    Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
    Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying cardiac transplant rejection in children: diagnostic utility of echocardiography, right heart catheterization and endomyocardial biopsy data.
    Rosenthal DN; Chin C; Nishimura K; Perry SB; Robbins RC; Reitz B; Bernstein D; Feinstein JA
    J Heart Lung Transplant; 2004 Mar; 23(3):323-9. PubMed ID: 15019642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnosis of rejection after heart transplantation].
    Nunoda S
    Kyobu Geka; 2007 Jul; 60(8 Suppl):685-91. PubMed ID: 17763670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome.
    Yamani MH; Haji SA; Starling RC; Tuzcu EM; Ratliff NB; Cook DJ; Abdo A; Crowe T; Secic M; McCarthy P; Young JB
    J Am Coll Cardiol; 2002 Mar; 39(6):970-7. PubMed ID: 11897438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular testing for long-term rejection surveillance in heart transplant recipients: design of the Invasive Monitoring Attenuation Through Gene Expression (IMAGE) trial.
    Pham MX; Deng MC; Kfoury AG; Teuteberg JJ; Starling RC; Valantine H
    J Heart Lung Transplant; 2007 Aug; 26(8):808-14. PubMed ID: 17692784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.
    Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR
    J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Routine C4d immunohistochemistry in cardiac allografts: Long-term outcomes.
    Husain AN; Mirza KM; Fedson SE
    J Heart Lung Transplant; 2017 Dec; 36(12):1329-1335. PubMed ID: 28988608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronary Angiography for Follow-up of Heart Transplant Recipients: Usefulness of the Gensini Score.
    Karaçağlar E; Akgün AN; Müderrisoğlu IH; Haberal M
    Exp Clin Transplant; 2020 Jan; 18(Suppl 1):99-104. PubMed ID: 32008508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T1 Mapping by Cardiac Magnetic Resonance and Multidimensional Speckle-Tracking Strain by Echocardiography for the Detection of Acute Cellular Rejection in Cardiac Allograft Recipients.
    Sade LE; Hazirolan T; Kozan H; Ozdemir H; Hayran M; Eroglu S; Pirat B; Sezgin A; Muderrisoglu H
    JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1601-1614. PubMed ID: 29680337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of dual imaging stress echocardiography for the diagnosis of coronary allograft vasculopathy in heart transplant recipients.
    Pichel IÁ; Fernández Cimadevilla OC; de la Hera Galarza JM; Pasanisi E; Ruiz JMG; Molina BD; Rodriguez JLL; Sicari R; Fernández MM
    Int J Cardiol; 2019 Dec; 296():109-112. PubMed ID: 31324395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Comprehensive Excursus of the Roles of Echocardiography in Heart Transplantation Follow-Up.
    Bacich D; Tessari C; Ciccarelli G; Lucertini G; Cerutti A; Pradegan N; Toscano G; Di Salvo G; Gambino A; Gerosa G
    J Clin Med; 2024 May; 13(11):. PubMed ID: 38892916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of speckle-tracking echocardiography-derived strain and systolic strain rate measurements to predict rejection in transplant hearts with preserved ejection fraction.
    Tseng AS; Gorsi US; Barros-Gomes S; Miller FA; Pellikka PA; Clavell AL; Villarraga HR
    BMC Cardiovasc Disord; 2018 Dec; 18(1):241. PubMed ID: 30579333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune function surveillance: association with rejection, infection and cardiac allograft vasculopathy.
    Heikal NM; Bader FM; Martins TB; Pavlov IY; Wilson AR; Barakat M; Stehlik J; Kfoury AG; Gilbert EM; Delgado JC; Hill HR
    Transplant Proc; 2013; 45(1):376-82. PubMed ID: 23267802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients.
    Asimacopoulos EP; Garbern JC; Gauvreau K; Blume ED; Daly KP; Singh TP
    Transplantation; 2020 Jan; 104(1):e31-e37. PubMed ID: 31568274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stress echocardiography: abnormal tissue Doppler imaging in the absence of cardiac allograft vasculopathy in heart transplant recipients.
    Nguyen T; Ahmadie R; Fang T; Lytwyn M; Francis A; Barac I; Hussain F; Zieroth S; Jassal DS
    Echocardiography; 2009 Feb; 26(2):182-8. PubMed ID: 19054033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of imaging in the evaluation of heart transplant recipients].
    De Chiara B; Roubina E; Frigerio M; Parodi O
    Ital Heart J Suppl; 2005 Sep; 6(9):561-8. PubMed ID: 16281715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Quantitative dobutamine stress echocardiography in follow-up of heart transplantation: normal values and findings in patients with transplant vasculopathy].
    Spes CH; Klauss V; Mudra H; Schnaack SD; Tammen AR; Weisenseel P; Rieber J; Henneke KH; Uberfuhr P; Reichart B; Theisen K; Angermann CE
    Z Kardiol; 1997 Oct; 86(10):868-76. PubMed ID: 9454455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three-Dimensional Speckle-Tracking Echocardiographic Monitoring of Acute Rejection in Heart Transplant Recipients.
    Du GQ; Hsiung MC; Wu Y; Qu SH; Wei J; Yin WH; Tian JW
    J Ultrasound Med; 2016 Jun; 35(6):1167-76. PubMed ID: 27105950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Stratification for Cardiac Allograft Vasculopathy in Heart Transplant Recipients - Annual Intravascular Ultrasound Evaluation.
    Sato T; Seguchi O; Ishibashi-Ueda H; Yanase M; Okada N; Kuroda K; Hisamatsu E; Sunami H; Watanabe T; Nakajima S; Wada K; Hata H; Fujita T; Fukushima N; Kobayashi J; Nakatani T
    Circ J; 2016; 80(2):395-403. PubMed ID: 26701183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunosuppressive T-cell antibody induction for heart transplant recipients.
    Penninga L; Møller CH; Gustafsson F; Gluud C; Steinbrüchel DA
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008842. PubMed ID: 24297433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.